LASTET INJ 100MG 5 ML

AboutLASTET INJ 100MG 5 ML VIAL contains Etoposide, a semisynthetic derivative of podophyllotoxin, classified as a topoisomerase II inhibitor. This chemotherapy agent exerts its cytotoxic effects by forming a ternary complex with topoisomerase II and DNA, preventing the re-ligation of DNA strands after cleavage. This leads to an accumulation of DNA breaks, ultimately triggering apoptosis in rapidly proliferating cancer cells. Etoposide is cell cycle phase-specific, primarily acting in the late S and G2 phases. Its mechanism of action makes it highly effective against a range of solid tumors and hematologic malignancies. It is frequently used in combination chemotherapy regimens to enhance overall treatment efficacy. Due to its potential for significant myelosuppression and other adverse effects, careful dosing, administration, and patient monitoring are essential throughout the treatment course to manage toxicities effectively and optimize therapeutic outcomes.UsesTreatment of small cell lung cancerManagement of testicular cancerTherapy for Hodgkin's and non-Hodgkin's lymphomaUsed in certain types of acute myeloid leukemiaDirections For UseAdministered intravenously by a qualified healthcare professional. Dosage and infusion rate are determined by the patient's condition and treatment protocol.BenefitsEffective against various solid tumorsInduces apoptosis in rapidly dividing cancer cellsPart of established combination chemotherapy regimensContributes to improved remission ratesWell-tolerated in some treatment protocolsOffers a crucial option for refractory cancersSide EffectsMyelosuppression (low blood counts)Nausea and vomitingAlopecia (hair loss)Fatigue and malaiseMucositis or stomatitisDiarrhea or abdominal painPeripheral neuropathy (rare)Hypersensitivity reactionsHypotension (with rapid infusion)Liver enzyme elevationsIncreased risk of infectionsAnorexiaSafety MeasuresAlcohol - Avoid alcohol consumption during treatment as it may exacerbate liver toxicity and general side effects of chemotherapy.Pregnancy - Contraindicated. Etoposide is teratogenic and can cause severe fetal harm. Effective contraception is mandatory.Breastfeeding - Contraindicated. The drug is excreted in breast milk and can cause serious adverse effects in the infant.Liver - Use with caution in patients with hepatic impairment. Dose adjustments may be necessary based on liver function tests.Kidney - Use with caution in patients with renal impairment. Dose adjustments may be necessary based on creatinine clearance.Lung - Rare cases of interstitial pneumonitis have been reported; monitor for any new or worsening respiratory symptoms.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.